Martín-Flores, N., Fernández-Santiago, R., Antonelli, F., Cerquera, C., Moreno, V., Martí, M. J., Ezquerra, M., & Malagelada, C. (2019). MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients. Molecular Neurobiology, 56(3), 2092-2100. https://doi.org/10.1007/s12035-018-1219-1
ISO-690 (author-date, English)MARTÍN-FLORES, Núria, FERNÁNDEZ-SANTIAGO, Rubén, ANTONELLI, Francesa, CERQUERA, Catalina, MORENO, Verónica, MARTÍ, Maria Josep, EZQUERRA, Mario und MALAGELADA, Cristina, 2019. MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients. Molecular Neurobiology. 1 März 2019. Vol. 56, no. 3, p. 2092-2100. DOI 10.1007/s12035-018-1219-1.
Modern Language Association 9th editionMartín-Flores, N., R. Fernández-Santiago, F. Antonelli, C. Cerquera, V. Moreno, M. J. Martí, M. Ezquerra, und C. Malagelada. „MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients“. Molecular Neurobiology, Bd. 56, Nr. 3, März 2019, S. 2092-00, https://doi.org/10.1007/s12035-018-1219-1.
Mohr Siebeck - Recht (Deutsch - Österreich)Martín-Flores, Núria/Fernández-Santiago, Rubén/Antonelli, Francesa/Cerquera, Catalina/Moreno, Verónica/Martí, Maria Josep u. a.: MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients, Molecular Neurobiology 2019, 2092-2100.
Emerald - HarvardMartín-Flores, N., Fernández-Santiago, R., Antonelli, F., Cerquera, C., Moreno, V., Martí, M.J., Ezquerra, M. und Malagelada, C. (2019), „MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients“, Molecular Neurobiology, Vol. 56 No. 3, S. 2092-2100.